4//SEC Filing
PLATZER ERICH 4
Accession 0001567619-21-022331
CIK 0000882361other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:33 PM ET
Size
8.7 KB
Accession
0001567619-21-022331
Insider Transaction Report
Form 4
PLATZER ERICH
Director
Transactions
- Purchase
Common Shares
2021-12-16$1.40/sh+20,000$28,000→ 505,000 total - Purchase
Common Shares
2021-12-16$1.38/sh+30,000$41,400→ 485,000 total - Purchase
Common Shares
2021-12-16$1.37/sh+50,000$68,500→ 455,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.365 to $1.39, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.395 to $1.40, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001275087
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:33 PM ET
- Size
- 8.7 KB